Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma Meeting Abstract


Authors: Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; Bains, M. S.
Abstract Title: Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
Meeting Title: 2012 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 4 Suppl.
Meeting Dates: 2012 Jan 19-21
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-02-01
Language: English
ACCESSION: WOS:000209849300070
DOI: 10.1200/jco.2012.30.4_suppl.67
PROVIDER: wos
Notes: Meeting Abstract: 67 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    864 Rusch
  2. Karyn A Goodman
    257 Goodman
  3. Nabil Rizk
    139 Rizk
  4. Marinela Capanu
    385 Capanu
  5. Yelena Yuriy Janjigian
    394 Janjigian
  6. Abraham Jing-Ching Wu
    400 Wu
  7. Manish Shah
    177 Shah
  8. David H Ilson
    433 Ilson
  9. Manjit S Bains
    338 Bains
  10. David P Kelsen
    537 Kelsen